Sapheon Raises $10M for U.S. Launch of Venous Reflux Treatment Device

Sapheon, a medical device company that develops new approaches for the treatment of vascular disease, has raised $10 million to commercially launch its VenaSeal Sapheon Closure System in the United States, according to a Triangle Business Journal report.

Advertisement

VenaSeal Sapheon Closure System can be used to treat venous reflux, which causes varicose veins.

Sapheon is awaiting approval from the U.S. Food and Drug Administration for its product. In Europe, it has sold 1,700 units, according to the report.

More Articles on Supply Chain:

Reducing Supply Chain Costs
First Navio Unicondylar Knee Replacement Performed in France
Abrams Royal Pharmacy Issues Voluntary Recall on All Unexpired Sterile Products

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.